Rescue of kidney function in a toddler with anti-GBM nephritis

Anti-glomerular basement membrane (anti-GBM) nephritis is rare in childhood with few published cases. We report a 19-month-old boy with rapidly progressive glomerulonephritis (RPGN) due to anti-GBM nephritis. Treatment was started under 2 weeks after presentation and included plasma exchange, intravenous high-dose methylprednisolone, intravenous cyclophosphamide and mycophenolate as mainstay medication. The treatment was rapidly effective with immediate decrease in anti-GBM titres and plasma creatinine. Three years after presentation, the boy has normal kidney function, blood pressure and no residual disease. The successful outcome was likely due to the rapid recognition of the anti-GBM antibodies as the cause of RPGN and aggressive primary treatment.

[1]  Amber P. Sanchez,et al.  Therapeutic Apheresis for Renal Disorders , 2012, Seminars in dialysis.

[2]  Ming-hui Zhao,et al.  Anti-Glomerular Basement Membrane Disease: Outcomes of Different Therapeutic Regimens in a Large Single-Center Chinese Cohort Study , 2011, Medicine.

[3]  A. Kıykım,et al.  Successful treatment of resistant antiglomerular basement membrane antibody positivity with mycophenolic acid. , 2010, Internal medicine.

[4]  S. Williamson,et al.  A 25-year experience with pediatric anti-glomerular basement membrane disease , 2010, Pediatric Nephrology.

[5]  S. Waller,et al.  Anti-GBM antibodies co-exist with MPO–ANCA in a 4-year-old girl with acute renal failure , 2009, Pediatric Nephrology.

[6]  Ç. Kasapkara,et al.  Successful management of anti-GBM disease in a 5½-year-old girl , 2006 .

[7]  Ç. Kasapkara,et al.  Successful management of anti-GBM disease in a 5 1/2-year-old girl. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Y. Asano,et al.  Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  M. Shah,et al.  Characteristics and Outcomes of Patients With Goodpasture's Syndrome , 2002, Southern medical journal.

[10]  J. Levy,et al.  Long-Term Outcome of AntiGlomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression , 2001, Annals of Internal Medicine.

[11]  S. Bigler,et al.  An 11-month-old with anti-glomerular basement membrane disease. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Marck,et al.  Anti-glomerular basement membrane glomerulopathy in a young child , 1996, Pediatric Nephrology.

[13]  R. Kalluri,et al.  The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  O. Pullig,et al.  Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Pincott,et al.  Goodpasture's syndrome: treatment with plasmapheresis, immunosuppression, and anticoagulation. , 1983, Archives of disease in childhood.